Zai Lab (ZLAB) Non-Current Deffered Revenue (2016 - 2026)
Zai Lab's (ZLAB) quarterly Non-Current Deffered Revenue came in at $28.6 million in Q1 2026, down 4.98% year-on-year from $30.1 million in Q1 2025, and up 4.73% quarter-over-quarter from $27.3 million in Q4 2025.
Zai Lab (ZLAB) Non-Current Deffered Revenue (2016 - 2026) Analysis & Trends
Zai Lab has disclosed Non-Current Deffered Revenue across 8 years of filings, most recently posting $28.6 million for Q1 2026.
- Non-Current Deffered Revenue for Q1 2026 came in at $28.6 million, down 4.98% year-over-year; the trailing twelve-month figure through Mar 2026 was $28.6 million (down 4.98% YoY), and the FY2025 annual result was $27.3 million, down 13.04% from the prior year.
- Non-Current Deffered Revenue came in at $28.6 million for Q1 2026 at Zai Lab, up from $27.3 million in the prior quarter.
- In the past five years, Non-Current Deffered Revenue ranged from a high of $31.4 million in Q4 2024 to a low of $21.4 million in Q4 2022.
- The 5-year median for Non-Current Deffered Revenue is $27.9 million (2023), against an average of $27.3 million.
- Across the five-year window, Non-Current Deffered Revenue dropped 22.29% in 2022 and surged 34.54% in 2023, its largest moves.
- Zai Lab's Non-Current Deffered Revenue stood at $21.4 million in 2022, then soared by 34.54% to $28.7 million in 2023, then gained by 9.38% to $31.4 million in 2024, then decreased by 13.04% to $27.3 million in 2025, then climbed by 4.73% to $28.6 million in 2026.
- The last three Non-Current Deffered Revenue figures came in at $28.6 million (Q1 2026), $27.3 million (Q4 2025), and $28.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Zai Lab | 20.15 Bn | 20.05 Bn | 61.30 Mn | 28.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 28.63 Mn |
| Dec 31, 2025 | 27.33 Mn |
| Sep 30, 2025 | 28.06 Mn |
| Jun 30, 2025 | 29.23 Mn |
| Mar 31, 2025 | 30.13 Mn |
| Dec 31, 2024 | 31.43 Mn |
| Sep 30, 2024 | 24.92 Mn |
| Jun 30, 2024 | 25.34 Mn |
| Mar 31, 2024 | 26.30 Mn |
| Dec 31, 2023 | 28.74 Mn |
| Sep 30, 2023 | 27.69 Mn |
| Jun 30, 2023 | 28.63 Mn |
| Mar 31, 2023 | 30.97 Mn |
| Dec 31, 2022 | 21.36 Mn |
| Sep 30, 2022 | 23.21 Mn |
| Jun 30, 2022 | 24.78 Mn |
| Dec 31, 2021 | 27.49 Mn |
| Dec 31, 2017 | 2.39 Mn |
| Dec 31, 2016 | 778,434.00 |